首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1563370

藥物發現服務市場規模、佔有率、成長分析、按流程、按類型、按藥物類型、按治療領域、按最終用戶、按地區 - 行業預測，2024-2031 年

Drug Discovery Services Market Size, Share, Growth Analysis, By Process, By Type, By Drug Type, By Therapeutic Area, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月29日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球藥物發現服務市場規模為201億美元，從2023年的230.7億美元成長到2031年的696.1億美元，預計預測期間（2024-2031年）複合年成長率為14.80%。。

全球藥物發現服務市場是製藥和生物技術行業快速成長的一部分，專注於開發各種疾病的新治療方法。市場提供廣泛的服務來支持複雜且資源集中的藥物發現過程。藥物發現包括識別和檢驗潛在的藥物標靶、創建候選藥物以及嚴格的安全性和有效性測試。由於這個過程成本高且耗時，製藥和生物技術公司越來越依賴專業服務提供者來幫助簡化和加速藥物開發。這些服務提供者利用先進技術、行業專業知識和基礎設施來最佳化藥物發現。這些服務供應商提供的服務包括標靶識別和檢驗、命中化合物識別、先導化合物最佳化、藥物化學以及體外和體內測試。我們也支持臨床前開發和早期臨床試驗。隨著對創新治療方法的需求持續上升，全球藥物發現服務市場在加速藥物開發方面發揮關鍵作用。隨著研發投入的增加，該市場預計未來將大幅擴大。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Laboratory Corporation of America Holdings（US）
Charles River Laboratories International, Inc.（US）
Wuxi APPTEC（China）
Pharmaron Beijing Co., Ltd.（China）
Evotec SE（Germany）
Eurofins Scientific SE（Luxembourg）
Piramal Enterprises Limited（India）
Syngene International Limited（India）
Genscript Biotech Corporation（China）
Jubilant Pharmova Limited（India）
Frontage Holdings Corporation（China）
Shanghai Medicilon Inc.（China）
Aurigene Discovery Technologies（Dr. Reddy's Laboratories）（India）
Sygnature Discovery Ltd.（UK）
Oncodesign Services（France）
Selvita SA（Poland）
Viva Biotech Holdings（China）
TCG Lifesciences Pvt Ltd.（India）
Shanghai Chempartner Co., Ltd.（China）
Domainex Ltd.（UK）
Nuvisan Pharma Holding GmbH（Germany）
Dalton Pharma Services（Canada）
Aragen Life Sciences Pvt. Ltd.（India）
Promega Corporation（US）

簡介目錄

Product Code: SQMIG35J2059

Global Drug Discovery Services Market size was valued at USD 20.10 billion in 2022 and is poised to grow from USD 23.07 billion in 2023 to USD 69.61 billion by 2031, growing at a CAGR of 14.80% during the forecast period (2024-2031).

The Global Drug Discovery Services Market is a rapidly growing sector within the pharmaceutical and biotechnology industries, focused on developing new treatments for various diseases. This market offers a broad range of services that assist in the complex and resource-intensive process of drug discovery. Drug discovery involves identifying and validating potential drug targets, creating drug candidates, and conducting rigorous safety and efficacy testing. Given the high cost and lengthy timelines associated with this process, pharmaceutical and biotech companies increasingly rely on specialized service providers to help streamline and accelerate drug development. These service providers utilize advanced technologies, industry expertise, and infrastructure to optimize drug discovery. Their offerings include target identification and validation, hit identification, lead optimization, medicinal chemistry, as well as in vitro and in vivo testing. They also support preclinical development and early-phase clinical trials. As the demand for innovative therapies continues to rise, the Global Drug Discovery Services Market plays a crucial role in accelerating drug development. With growing investments in research and development, this market is poised for significant expansion in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segmental Analysis

Global Drug Discovery Services Market is segmented by Process, Type, Drug Type, Therapeutic Area, and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, and Candidate Validation. Based on Type, the market is segmented into Chemistry Services, and Biology Services. Based on Drug Type, the market is segmented into Small-Molecule Drugs, and Biologics. Based on Therapeutic Area, the market is segmented into Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Immunological Disorders, Endocrine & Metabolic Disorders, Respiratory Disorders, Digestive System Diseases, Genitourinary Diseases & Women's Health, and Other Therapeutic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Drug Discovery Services Market

The increasing demand for innovative treatments for chronic diseases, along with advancements in the global healthcare sector, are expected to be key drivers of growth in the drug discovery services market. Pharmaceutical and biopharmaceutical companies continue to outsource their research and development (R&D) activities to contract research organizations (CROs), which provide specialized R&D services. These CROs are helping to optimize R&D processes through tailored engagement models, thereby improving efficiency in drug development. The growing burden of chronic diseases has also prompted governments and pharmaceutical companies to seek effective solutions and invest more heavily in clinical trials. This heightened focus on addressing chronic illnesses is driving the need for drug discovery services. As the demand for novel therapies increases, so too will the reliance on these services to support drug development efforts across the healthcare industry.

Restraints in the Global Drug Discovery Services Market

The market is expected to face two significant challenges: a shortage of skilled labor and the high failure rate of target drug molecules. The lack of trained professionals in drug discovery and development could slow down progress, as expertise is critical for advancing complex research and development processes. Additionally, the high failure rate of drug molecules in the early stages of development poses a major hurdle. Pharmaceutical companies invest millions of dollars in preclinical research to identify viable drug candidates, but when these molecules fail to meet expectations, it significantly increases the overall cost of drug development. This not only raises expenses but also adds pressure on the industry to find more efficient solutions.

Market Trends of the Global Drug Discovery Services Market

The Global Drug Discovery Services Market is witnessing several important trends that are shaping its future. One major trend is the growing reliance on outsourcing, as pharmaceutical and biotech companies increasingly turn to specialized service providers for their drug discovery needs. This approach allows companies to leverage external expertise, advanced technology, and cost-effective solutions while concentrating on their core business operations. Another key development is the rise in collaborative partnerships between pharmaceutical companies and contract research organizations (CROs). These alliances promote resource sharing, knowledge exchange, and risk-sharing, driving innovation and speeding up the drug discovery process. Technological advancements are also transforming the drug discovery services market. Cutting-edge technologies like high-throughput screening, artificial intelligence, and genomics are significantly enhancing the drug discovery process. These innovations enable quicker, more precise identification and optimization of drug candidates, leading to more efficient and successful outcomes in the development of new therapies. As a result, these trends are driving growth and fostering further evolution within the industry.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Technology Analysis
Pricing Analysis
Customer & Buying Criteria Analysis

Drug Discovery Services Market by Process

Market Overview
Target Selection
Target Validation
Hit-To-Lead Identification
Lead Optimization
Candidate Validation

Drug Discovery Services Market by Type

Market Overview
Chemistry Services
Biology Services

Drug Discovery Services Market by Drug Type

Market Overview
Small-Molecule Drugs
Biologics

Drug Discovery Services Market by Therapeutic Area

Market Overview
Oncology
Infectious Diseases
Cardiovascular Diseases
Neurological Diseases
Immunological Disorders
Endocrine & Metabolic Disorders
Respiratory Disorders
Digestive System Diseases
Genitourinary Diseases & Women's Health
Other Therapeutic Areas

Drug Discovery Services Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
- Tier 1 Companies
- Tier 2 Companies
- Tier 3 Companies
Academic Institutes
Other End Users

Drug Discovery Services Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi APPTEC (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron Beijing Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evotec SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Enterprises Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syngene International Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Pharmova Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Holdings Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Medicilon Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurigene Discovery Technologies (Dr. Reddy's Laboratories) (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sygnature Discovery Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oncodesign Services (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Selvita S.A. (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viva Biotech Holdings (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TCG Lifesciences Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Chempartner Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Domainex Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvisan Pharma Holding GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dalton Pharma Services (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aragen Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments